Neuro-Hitech Buys Q-RNA

Neuro-Hitech Inc. (OTC BB: NHPI) has agreed to acquire Q-RNA Inc., a New York-based biotech company focused on conditions such as Alzheimer’s, epilepsy and Parkinson’s disease. The deal is valued at nearly $11 million in stock, plus an agreement whereby Q-RNA shareholders will commit at least $3.1 million to the combined company. Q-RNA has raised a funding from firms like Wheatley Partners, Double D Venture Fund and Durand Venture Associates. < ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />